Back to Search
RALPH WEICHSELBAUM, M.D.
M.D.
Radiation Oncology Physician
NPI: 1578510749Individual
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
34518(MA)
Research & Publications (20)
Translation of the radio- and chemo-inducible TNFerade vector to the treatment of human cancers.
PMID 19444302·Cancer Gene Ther·2009
8-other
An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer.
PMID 19001271·Proc Natl Acad Sci U S A·2008
4-observational
How does antiangiogenic therapy affect brain tumor response to radiation?
PMID 16264953·Nat Clin Pract Oncol·2005
7-preclinical
Radiation-induced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapy.
PMID 12424068·Lancet Oncol·2002
6-review
Concomitant proliferation and caspase-3 mediated apoptosis in response to low shear stress and balloon injury.
PMID 19482308·J Surg Res·2010
7-preclinical
Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment.
PMID 19349616·Blood·2009
7-preclinical
Extraction and assembly of tissue-derived gels for cell culture and tissue engineering.
PMID 19115821·Tissue Eng Part C Methods·2009
7-preclinical
Translational strategies exploiting TNF-alpha that sensitize tumors to radiation therapy.
PMID 18974777·Cancer Gene Ther·2009
7-preclinical
Biochemical control and toxicity after intensity-modulated radiation therapy for prostate cancer.
PMID 19445537·Technol Cancer Res Treat·2009
8-other
MUC1-induced transcriptional programs associated with tumorigenesis predict outcome in breast and lung cancer.
PMID 19318547·Cancer Res·2009
7-preclinical
Radioresistance of Stat1 over-expressing tumour cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signalling.
PMID 19437244·Int J Radiat Biol·2009
7-preclinical
Dose-escalated radiation therapy for intermediate-risk prostate cancer: patient selection for androgen deprivation therapy using percentage of positive cores.
PMID 19208426·Cancer·2009
8-other
MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment.
PMID 19289846·Proc Natl Acad Sci U S A·2009
8-other
Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials?
PMID 19029997·Nat Clin Pract Gastroenterol Hepatol·2009
6-review
Characterization of response to radiation mediated gene therapy by means of multimodality imaging.
PMID 19449382·Magn Reson Med·2009
7-preclinical
STAT1 pathway mediates amplification of metastatic potential and resistance to therapy.
PMID 19503789·PLoS One·2009
7-preclinical
Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy.
PMID 19340870·Head Neck·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5758 S MARYLAND AVE, MC9006
CHICAGO, IL 60637 - Phone
- (773) 702-0817
Quick Facts
- NPI
- 1578510749
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile